Overview

Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is the evaluation of PK/PD target attainment of amikacin in ED patients with severe sepsis and septic shock.
Phase:
Phase 4
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Treatments:
Amikacin